All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

A Novel Strategy for Preventing and Treating Cancer: Alteration of Cancer-Associated Chromatin Configuration

DOI: 10.4236/oalib.1107347, PP. 1-7

Subject Areas: Oncology, Molecular Biology, Cell Biology

Keywords: Cancer, Cancer-Associated Chromatin Configuration (CACC), Non-Carcinogenic Genotoxic Drugs (NCGDs), Cancer Prevention, Cancer Treatment

Full-Text   Cite this paper   Add to My Lib

Abstract

The hallmarks of cancer are determined by cancer-associated gene expression pattern that is determined by cancer-associated chromatin configuration (CACC). Using non-carcinogenic genotoxic drugs (NCGDs) to alter CACC could change cancer-associated gene expression pattern, which in turn, might cause disappearance of some or whole hallmarks of cancer and as a result, cancer cells could be killed by either apoptosis or immune destruction. Therefore, cancer could be prevented and treated by administration of NCGDs that can alter CACC in cancer cells.

Cite this paper

Li, G. (2021). A Novel Strategy for Preventing and Treating Cancer: Alteration of Cancer-Associated Chromatin Configuration. Open Access Library Journal, 8, e7347. doi: http://dx.doi.org/10.4236/oalib.1107347.

References

[1]  Li, G.D. (1986) Abnormal Chromatin Configuration and Oncogenesis. Medicine and Philosophy, 7, 12-14. (In Chinese)
[2]  Corces, M.R. and Corces, V.G. (2016) The Three-Dimensional Cancer Genome. Current Opinion in Genetics & Development, 36, 1-7. https://doi.org/10.1016/j.gde.2016.01.002
[3]  Flavahan, W.A., Drier, Y., Liau, B.B., Gillespie, S.M., Venteicher, A.S., Suva, M.L., Stem-Mer-Rachamimov, A.O. and Bernstein, B.E. (2016) Insulator Dysfunction and Oncogene Activation in IDH Mutant Gliomas. Nature, 529, 110-114. https://doi.org/10.1038/nature16490
[4]  Feng, Y. and Pauklin, S. (2020) Revisiting 3D Chromatin Architecture in Cancer Development and Progression. Nucleic Acids Research, 48, 10632-10647. https://doi.org/10.1093/nar/gkaa747
[5]  Li, G.D. (2019) Further Thoughts on Abnormal Chromatin Configuration and Oncogenesis. Open Access Library Journal, 6, e5185. https://doi.org/10.4236/oalib.1105185
[6]  Kantidze, O.L., Luzhin, A.V., Nizovtseva, E.V., Safina, A., Valieva, M.E. and Golov,A.K., et al. (2019) The Anti-Cancer Drugs Curaxins Target Spatial Genome Organization. Nature Communications, 10, Article No. 1441. https://doi.org/10.1038/s41467-019-09500-7
[7]  Hanahan, D. and Weinberg, R.A. (2000) The Hallmarks of Cancer. Cell, 100, 57-70. https://doi.org/10.1016/S0092-8674(00)81683-9
[8]  Li, G.D. (2020) Targeting Three-Dimensional Genome Architecture Might Be One of the Mechanisms of Chloroquine’s Diverse Therapeutic Actions. Open Access Library Journal, 7, e6340. http://doi.org/10.4236/oalib.1106340
[9]  Li, G.D. (2020) Non-Carcinogenic Genotoxic Drugs Could Be Used to Prevent and Treat COVID-19. Open Access Library Journal, 7, e6536. https://doi.org/10.4236/oalib.1106536
[10]  Yan, M. and Liu, Q. (2016) Differentiation Therapy: A Promising Strategy for Cancer Treatment. Chinese Journal of Cancer, 35, Article No. 3. https://doi.org/10.1186/s40880-015-0059-x
[11]  Alakhras, RS., Stephanou, G., Demopoulos, N.A. and Nikolaropoulos, S.S. (2011) Genotoxicity of All-Trans Retinoic Acid (ATRA) and Its Steroidal Analogue EA-4 in Human Lymphocytes and Mouse Cells in Vitro. Cancer Letters, 306, 15-26. https://doi.org/10.1016/j.canlet.2011.02.010
[12]  Miller Jr., W.H., Schipper, H.M., Lee, J.S., Singer, J. and Waxman, S. (2002) Mechanisms of Action of Arsenic Trioxide. Cancer Research, 62, 3893-903.
[13]  Cole, W.H. and Everson, T.C. (1956) Spontaneous Regression of Cancer: Preliminary Report. Annals of Surgery, 144, 366-383. https://doi.org/10.1097/00000658-195609000-00007
[14]  Turkez. H., Arslan, M.E. and Ozdemir, O. (2017) Genotoxicity Testing: Progress and Prospects for the Next Decade. Expert Opinion on Drug Metabolism & Toxicology, 13, 1089-1098. https://doi.org/10.1080/17425255.2017.1375097
[15]  Butt, G., Farooqi, A.A., Adylova, A., Attar, R., Yilmaz, S., Konysbayevna, K.K., Sabitaliyevich, U.Y., Gasparri, M.L. and Xu, B. (2020) Vitamin C as an Anticancer Agent: Regulation of Signaling Pathways. Current Topics in Medicinal Chemistry, 20, 1868-1875. https://doi.org/10.2174/1568026620666200710102841
[16]  Song, Y., Zhong, X., Gao, P., Zhou, C., Shi, J., Wu Z., Guo, Z. and Wang, Z. (2020) Aspirin and Its Potential Preventive Role in Cancer: An Umbrella Review. Frontiers in Endocrinology, 11, Article No. 3. https://doi.org/10.3389/fendo.2020.00003
[17]  Bonovas, S., Filioussi, K. and Sitaras, N.M. (2006) Paracetamol Use and Risk of Ovarian Cancer: A Meta-Analysis. British Journal of Clinical Pharmacology, 62, 113-121. https://doi.org/10.1111/j.1365-2125.2005.02526.x
[18]  Zhang, Y., Liao, Z., Zhang, L.J. and Xiao, H.T. (2015) The Utility of Chloroquine in Cancer Therapy. Current Medical Research and Opinion, 31, 1009-1013. https://doi.org/10.1185/03007995.2015.1025731
[19]  Vancura, A., Bu, P., Bhagwat, M., Zeng, J. and Vancurova, I. (2018) Metformin as an Anticancer Agent. Trends in Pharmacological Sciences, 39, 867-878. https://doi.org/10.1016/j.tips.2018.07.006
[20]  Tomeh, M.A., Hadianamrei, R. and Zhao, X. (2019) A Review of Curcumin and Its Derivatives as Anticancer Agents. International Journal of Molecular Sciences, 20, Article No. 1033. https://doi.org/10.3390/ijms20051033
[21]  Wang, Y., Liu, Y., Du, X., Ma, H. and Yao, J. (2020) The Anti-Cancer Mechanisms of Berberine: A Review. Cancer Management and Research, 12, 695-702. https://doi.org/10.2147/CMAR.S242329

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679